Cargando…

Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties

Hydroxymethylation is a simple chemical reaction, in which the introduction of the hydroxymethyl group can lead to physical–chemical property changes and offer several therapeutic advantages, contributing to the improved biological activity of drugs. There are many examples in the literature of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Soraya S., Gonzaga, Rodrigo V., Scarim, Cauê B., Giarolla, Jeanine, Primi, Marina C., Chin, Chung M., Ferreira, Elizabeth I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883432/
https://www.ncbi.nlm.nih.gov/pubmed/35237565
http://dx.doi.org/10.3389/fchem.2021.734983
_version_ 1784659925250605056
author Santos, Soraya S.
Gonzaga, Rodrigo V.
Scarim, Cauê B.
Giarolla, Jeanine
Primi, Marina C.
Chin, Chung M.
Ferreira, Elizabeth I.
author_facet Santos, Soraya S.
Gonzaga, Rodrigo V.
Scarim, Cauê B.
Giarolla, Jeanine
Primi, Marina C.
Chin, Chung M.
Ferreira, Elizabeth I.
author_sort Santos, Soraya S.
collection PubMed
description Hydroxymethylation is a simple chemical reaction, in which the introduction of the hydroxymethyl group can lead to physical–chemical property changes and offer several therapeutic advantages, contributing to the improved biological activity of drugs. There are many examples in the literature of the pharmaceutical, pharmacokinetic, and pharmacodynamic benefits, which the hydroxymethyl group can confer to drugs, prodrugs, drug metabolites, and other therapeutic compounds. It is worth noting that this group can enhance the drug’s interaction with the active site, and it can be employed as an intermediary in synthesizing other therapeutic agents. In addition, the hydroxymethyl derivative can result in more active compounds than the parent drug as well as increase the water solubility of poorly soluble drugs. Taking this into consideration, this review aims to discuss different applications of hydroxymethyl derived from biological agents and its influence on the pharmacological effects of drugs, prodrugs, active metabolites, and compounds of natural origin. Finally, we report a successful compound synthesized by our research group and used for the treatment of neglected diseases, which is created from the hydroxymethylation of its parent drug.
format Online
Article
Text
id pubmed-8883432
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88834322022-03-01 Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties Santos, Soraya S. Gonzaga, Rodrigo V. Scarim, Cauê B. Giarolla, Jeanine Primi, Marina C. Chin, Chung M. Ferreira, Elizabeth I. Front Chem Chemistry Hydroxymethylation is a simple chemical reaction, in which the introduction of the hydroxymethyl group can lead to physical–chemical property changes and offer several therapeutic advantages, contributing to the improved biological activity of drugs. There are many examples in the literature of the pharmaceutical, pharmacokinetic, and pharmacodynamic benefits, which the hydroxymethyl group can confer to drugs, prodrugs, drug metabolites, and other therapeutic compounds. It is worth noting that this group can enhance the drug’s interaction with the active site, and it can be employed as an intermediary in synthesizing other therapeutic agents. In addition, the hydroxymethyl derivative can result in more active compounds than the parent drug as well as increase the water solubility of poorly soluble drugs. Taking this into consideration, this review aims to discuss different applications of hydroxymethyl derived from biological agents and its influence on the pharmacological effects of drugs, prodrugs, active metabolites, and compounds of natural origin. Finally, we report a successful compound synthesized by our research group and used for the treatment of neglected diseases, which is created from the hydroxymethylation of its parent drug. Frontiers Media S.A. 2022-02-14 /pmc/articles/PMC8883432/ /pubmed/35237565 http://dx.doi.org/10.3389/fchem.2021.734983 Text en Copyright © 2022 Santos, Gonzaga, Scarim, Giarolla, Primi, Chin and Ferreira. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Chemistry
Santos, Soraya S.
Gonzaga, Rodrigo V.
Scarim, Cauê B.
Giarolla, Jeanine
Primi, Marina C.
Chin, Chung M.
Ferreira, Elizabeth I.
Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties
title Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties
title_full Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties
title_fullStr Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties
title_full_unstemmed Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties
title_short Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties
title_sort drug/lead compound hydroxymethylation as a simple approach to enhance pharmacodynamic and pharmacokinetic properties
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883432/
https://www.ncbi.nlm.nih.gov/pubmed/35237565
http://dx.doi.org/10.3389/fchem.2021.734983
work_keys_str_mv AT santossorayas drugleadcompoundhydroxymethylationasasimpleapproachtoenhancepharmacodynamicandpharmacokineticproperties
AT gonzagarodrigov drugleadcompoundhydroxymethylationasasimpleapproachtoenhancepharmacodynamicandpharmacokineticproperties
AT scarimcaueb drugleadcompoundhydroxymethylationasasimpleapproachtoenhancepharmacodynamicandpharmacokineticproperties
AT giarollajeanine drugleadcompoundhydroxymethylationasasimpleapproachtoenhancepharmacodynamicandpharmacokineticproperties
AT primimarinac drugleadcompoundhydroxymethylationasasimpleapproachtoenhancepharmacodynamicandpharmacokineticproperties
AT chinchungm drugleadcompoundhydroxymethylationasasimpleapproachtoenhancepharmacodynamicandpharmacokineticproperties
AT ferreiraelizabethi drugleadcompoundhydroxymethylationasasimpleapproachtoenhancepharmacodynamicandpharmacokineticproperties